Fibrinolysin, antagonists & inhibitors
- Name
- Fibrinolysin, antagonists & inhibitors
- Accession Number
- DBCAT003019
- Description
Not Available
- Drugs
Drug Drug Description Nafamostat Used as an anticoagulant in patients with disseminative blood vessel coagulation, hemorrhagic lesions, and hemorrhagic tendencies. It prevents blood clot formation during extracorporeal circulation in patients undergoing continuous renal replacement... Fibrinolysin Fibrinolysin assists with the healing of minor burns, superficial wounds, ulcers, surgical wounds, and superficial hematomas. - Drugs & Drug Targets